{
  "ptid_time": "128_S_0266_2007-04-12",
  "img_path": "/data/qiuhui/data/adni/images/128_S_0266/2007-04-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 98,026 mm³, 108.5% above the reference mean. With a Z-score of 3.15 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 5,463 mm³, 21.6% below the reference mean. With a Z-score of -1.87 (3.1th percentile), this represents moderate atrophy; whole brain volume measures 1,032,220 mm³, 0.3% above the reference mean. With a Z-score of 0.04 (51.6th percentile), this represents normal volume ; entorhinal cortex volume measures 2,488 mm³, 37.3% below the reference mean. With a Z-score of -2.44 (0.7th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,157 mm³, 10.6% below the reference mean. With a Z-score of -0.91 (18.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,543 mm³, 13.0% below the reference mean. With a Z-score of -1.17 (12.1th percentile), this represents mild atrophy. ",
  "text_data": "Age is 86.5 years. Gender is Male. Education: 20 years. MMSE: 25.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Pittsburgh compound B: 1.58 SUVR (normal ); Amyloid beta: 360.60 pg/mL (moderate reduced); Total tau: 118.00 pg/mL (moderate reduced); Phosphorylated tau: 10.41 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex) alongside profound ventricular enlargement, suggesting neurodegeneration. The MMSE score of 25 is borderline, and moderate Aβ reduction supports amyloid pathology, though tau levels are reduced, which is atypical for typical AD.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s pathology, but tau profile is unusual)  \n**Confidence:** **Medium** (due to conflicting tau biomarkers and age-related confounders)",
  "timestamp": "2025-07-26T13:43:24.785527"
}